References
- Zwagerman N, Sprague S, Davis MD, Daniels B, Goel G, Ding Y. Pre-ischemic exercise preserves cerebral blood flow during reperfusion in stroke. Neurol Res. 2010 Jun;32(5):523–29. doi:https://doi.org/10.1179/016164109X12581096796431.
- Randolph SA. Ischemic Stroke. Workplace Health Saf. 2016 Sep;64(9):444. doi:https://doi.org/10.1177/2165079916665400.
- Rabinstein AA. Treatment of acute ischemic stroke. Continuum (Minneapolis, Minn). 2017 Feb;23(1, Cerebrovascular Disease):62–81.
- Huang R, Ma J, Niu B, Li J, Chang J, Zhang Y, Liu P, Luan X. MiR-34b protects against focal cerebral ischemia-reperfusion (I/R) injury in rat by targeting keap1. Journal of Stroke and Cerebrovascular Diseases: The Official Journal of National Stroke Association. 2019 Jan;28(1):1–9. doi:https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.08.023.
- Gong L, Tang Y, An R, Lin M, Chen L, Du J. RTN1-C mediates cerebral ischemia/reperfusion injury via ER stress and mitochondria-associated apoptosis pathways. Cell Death Dis. 2017 Oct 5;8(10):e3080. doi:https://doi.org/10.1038/cddis.2017.465.
- Yu SY, Tang L, Zhou SH. Long noncoding RNAs: New players in ischaemia-reperfusion injury. Heart Lung Circ. 2018 Mar;27(3):322–32. doi:https://doi.org/10.1016/j.hlc.2017.09.011.
- Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018 Jan 25;172(3):393–407. doi: https://doi.org/10.1016/j.cell.2018.01.011.
- Wang J, Cao B, Han D, Sun M, Feng J. Long non-coding RNA H19 induces cerebral ischemia reperfusion injury via activation of autophagy. Aging Dis. 2017 Feb;8(1):71–84. doi:https://doi.org/10.14336/AD.2016.0530.
- Yin W, Yin W, Huang B, Wu L. LncRNA SNHG12 inhibits miR-199a to upregulate SIRT1 to attenuate cerebral ischemia/reperfusion injury through activating AMPK signaling pathway. Neurosci Lett. 2019 Jan 18;690:188–95. doi:https://doi.org/10.1016/j.neulet.2018.08.026.
- Liang J, Wang Q, Li JQ, Guo T, Yu D. Long non-coding RNA MEG3 promotes cerebral ischemia-reperfusion injury through increasing pyroptosis by targeting miR-485/AIM2 axis. Exp Neurol. 2020 Mar;325:113139. doi:https://doi.org/10.1016/j.expneurol.2019.113139.
- Cai J, Shangguan S, Li G, Cai Y, Chen Y, Ma G, Miao Z, Liu L, Deng Y. Knockdown of lncRNA Gm11974 protect against cerebral ischemic reperfusion through miR-766-3p/NR3C2 axis. Artif Cells, Nanomed Biotechnol. 2019 Dec;47(1):3847–53. doi:https://doi.org/10.1080/21691401.2019.1666859.
- Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014 Jan 16;505(7483):344–52. doi: https://doi.org/10.1038/nature12986.
- Wang X, Li XD, Fu Z, Zhou Y, Huang X, Jiang X. Long non‑coding RNA LINC00473/miR‑195‑5p promotes glioma progression via YAP1‑TEAD1‑Hippo signaling. Int J Oncol. 2020 Feb;56(2):508–21.
- Chen W, Zhang Y, Wang H, Pan T, Zhang Y, Li C. LINC00473/miR-374a-5p regulates esophageal squamous cell carcinoma via targeting SPIN1 to weaken the effect of radiotherapy. J Cell Biochem. 2019 Sep;120(9):14562–72. doi:https://doi.org/10.1002/jcb.28717.
- Zheng Y, Sun S, Yu M, Fu X. Identification of potential hub-lncRNAs in ischemic stroke based on Subpathway-LNCE method. J Cell Biochem. 2019 Aug;120(8):12832–42. doi:https://doi.org/10.1002/jcb.28554.
- He Z. LINC00473/miR-497-5p regulates esophageal squamous cell carcinoma progression through targeting PRKAA1. Cancer Biother Radiopharm. 2019 Dec;34(10):650–59. doi:https://doi.org/10.1089/cbr.2019.2875.
- Wang S, Wang X, Xu SL. LINC00473 promotes lung adenocarcinoma progression by regulating miR-1294/ROBO1 axis. J Biol Regul Homeost Agents. 2020;34:2.
- Huang L, Jiang X, Li Z, Li J, Lin X, Hu Z, Cui Y. Linc00473 potentiates cholangiocarcinoma progression by modulation of DDX5 expression via miR-506 regulation. Cancer Cell Int. 2020;20(1):324. doi:https://doi.org/10.1186/s12935-020-01415-4.
- Hao X-F, Zhang Y-X, Wang X-X, Sun W, Zhao J, Chen G-R. LINC00473 functions as an oncogene and predicts poor prognosis in pancreatic cancer via the cAMP/β-catenin axis. Eur Rev Med Pharmacol Sci. 2020 May;24(10):5345–52.
- Mo J, Li B, Zhou Y, Xu Y, Jiang H, Cheng X, Wu X, Zhang Y. LINC00473 promotes hepatocellular carcinoma progression via acting as a ceRNA for microRNA-195 and increasing HMGA2 expression. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2019 Dec;120:109403. doi:https://doi.org/10.1016/j.biopha.2019.109403.
- Bai J, Zhao W-Y, Li W-J, Ying Z-W, Jiang D-Q. Long noncoding RNA LINC00473 indicates a poor prognosis of breast cancer and accelerates tumor carcinogenesis by competing endogenous sponging miR-497. Eur Rev Med Pharmacol Sci. 2019 Apr;23(8):3410–20.
- Zhou W, Zhang M, Liu C, Kang Y, Wang J, Yang X. Long noncoding RNA LINC00473 drives the progression of pancreatic cancer via upregulating programmed death-ligand 1 by sponging microRNA-195-5p. J Cell Physiol. 2019 Dec;234(12):23176–89. doi:https://doi.org/10.1002/jcp.28884.
- Teng H, Li M, Qian L, Yang H, Pang M. Long non‑coding RNA SNHG16 inhibits the oxygen‑glucose deprivation and reoxygenation‑induced apoptosis in human brain microvascular endothelial cells by regulating miR‑15a‑5p/bcl‑2. Mol Med Rep. 2020 Oct;22(4):2685–94.
- Celik H, Kyun Koh W, Kramer AC, Ostrander EL, Mallaney C, Fisher DAC, Xiang J, Wilson WC, Martens A, Kothari A, et al. JARID2 functions as a tumor suppressor in myeloid neoplasms by repressing self-renewal in hematopoietic progenitor cells. Cancer Cell. 2018 Nov 12;34(5):741–756.e8. doi:https://doi.org/10.1016/j.ccell.2018.10.008.
- Wang X, Lyu J, Ji A, Zhang Q, Liao G. Jarid2 enhances the progression of bladder cancer through regulating PTEN/AKT signaling. Life Sci. 2019 Aug 1;230:162–68. doi:https://doi.org/10.1016/j.lfs.2019.05.053.
- Mejetta S, Morey L, Pascual G, Kuebler B, Mysliwiec MR, Lee Y, Shiekhattar R, Di Croce L, Benitah SA. Jarid2 regulates mouse epidermal stem cell activation and differentiation. EMBO J. 2011 Aug 2;30(17):3635–46. doi:https://doi.org/10.1038/emboj.2011.265.